Show Summary Details
Page of

Parallel-Design Double-blind Trials 

Parallel-Design Double-blind Trials
Study Design and Statistics

AMA Manual of Style Committee

Page of

PRINTED FROM AMA MANUAL OF STYLE ONLINE ( © American Medical Association, 2009. All Rights Reserved. Under the terms of the license agreement, an individual user may print out a PDF of a single chapter of a title in AMA Manual of Style Online for personal use (for details see Privacy Policy and Legal Notice).

date: 21 January 2020

In this study design, participants are assigned to only 1 treatment group of the study. These trials are generally designed to assess whether 1 or more treatments are superior to the others. Participants and those administering the intervention should all be unaware of which intervention individual participants are receiving (“double-blinding”). Ideally, those rating the outcomes should also be blinded to treatment assignment (“triple-blinding”). Blinded parallel-design trials are often the optimal design to compare 2 or more types of drug or other therapy, since known and unknown potentially confounding factors should be randomly distributed between intervention and control groups. The CONSORT

Access to the complete content on AMA Manual of Style requires a subscription or purchase. Public users are able to search the site without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.